# 08 Risk Review

## Committee Decision

`REJECT` executable portfolio; publish `NO_TRADE`.

## Top Concerns

1. Portfolio beta feasibility fails: the max-capped investable basket reaches 0.522 NAV beta, below the protected 0.90 floor.
2. Repairing beta would require either sub-threshold monitor names or weights above the 5% single-name cap, both prohibited.
3. GS has a buffered estimated earnings window at 19 days, so its confidence is capped `LOW` even though it remains in the research-grade set.

## Checklist

| Check | Result |
| --- | --- |
| Price/target lineage | PASS: every ranked or monitored name has delayed Yahoo/Nasdaq-cross-checked price rows and target/CI formulas. |
| Sigma lineage | PASS: every forecast uses `REALIZED_VOL_30D`. |
| Score attribution | PASS: every ranked name has family z-scores, DQ, penalties, and source ledger rows. |
| Kelly handling | PASS: positive Kelly diagnostics, capped at 5%; no approved executable book. |
| Technical indicator lineage | PASS: fields cite `technical_indicators.json` and price-history rows. |
| Source Ledger completeness | PASS for required fields; enhancing feeds are disclosed as missing and not used as GO blockers. |
| Prediction records | PASS: `15_predictions.json` contains the three ETF market forecasts plus all ranked/monitor equity forecasts. |

## Final Publication Recommendation

Publish `NO_TRADE`. The research workflow is complete, but no portfolio can satisfy the protected beta band under the single-name cap.
